Neuropsychiatric Symptoms of Hepatitis C

REFERENCES

• Afdhal N., Dieterich D., Pockros P., et al. Epoetin alfa maintains ribavirin dose in HCV-infected patients: A prospective, double-blind, randomized controlled study. Gastroenterology 2004; 26: 1302–1311
   Google Scholar
• American Liver Foundation. Facts at a glance: Hepatitis C. 2007, [On-line]. Retrieved March 29, 2007, from www.liverfoundation.org
   Google Scholar
• Bagheri H., Fouladi A., Barange K., Lapeyre-Mestre J., Payen J., Montastruc L., Vinel J. Follow-up of adverse drug reactions from pegInterferon alpha2b-ribavirin therapy. Pharmacotherapy 2004; 24(11)1546–1553
   PubMedGoogle Scholar
• Bonaccorso S., Marino V., Puzella J., Pasquini M., Biondi M., Artini M., Almerighi C., Verkerk R., Meltzer H., Maes M. Increased depressive ratings in patients with hepatitis C receiving Interferon-alpha-based immunotherapy are related to Interferon-alpha-induced changes in the serotonergic system. Journal of Clinical Psychopharmacology 2002; 22(1)86–90
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Viral Hepatitis C—Fact sheet. 2007, [On-line]. Retrieved March 29, 2007, from http://www.cdc.gov/ncidod/diseases/hepatitis/c/fact.htm
   Google Scholar
• Constant A., Castera L., Dantzer R., Couzigou P., de Ledinghen V., Demotes-Mainard J., Henry C. Mood alterations during Interferon-alpha therapy in patients with chronic hepatitis C: Evidence for an overlap between manic/hypomanic and depressive symptoms. The Journal of Clinical Psychiatry 2005; 66(8)1050–1057
   PubMedGoogle Scholar
• Coughlan B., Sheehan J., Hickey A., Crowe J. Psychological well-being and quality of life in women with an iatrogenic hepatitis C virus infection. British Journal of Health Psychology 2002; 7: 105–116
   PubMed Web of Science ®Google Scholar
• Crone C., Gabriel G. Comprehensive review of hepatitis C for psychiatrists: Risks, screening, diagnosis, treatment, and Interferon-based therapy complications. Journal of Psychiatric Practice 2003; 9(2)93–110
   PubMedGoogle Scholar
• Debatista C., Solvason H., Poirier J., et al. A prospective trial of bupropion SR augmentation in partial and non-responders to serotonergic antidepressants. Journal of Psychopharmacology 2003; 23(1)27–30
   Google Scholar
• Dieperink E. Suicidal ideation during Interferon-alpha2b and ribavirin treatment of patients with chronic hepatitis C. General Hospital Psychiatry 2004; 26(3)237–240
   PubMed Web of Science ®Google Scholar
• Dieperink E., Ho S., Thuras P., Willenbring M. A prospective study of neuropsychiatric symptoms associated with Interferon-alpha2b and ribavirin therapy for patients with chronic hepatitis C. Psychomatics 2003; 44(2)104–112
   PubMed Web of Science ®Google Scholar
• Taking care of yourself nutritionally: Guidelines for healthy nutrition in liver disease. Living with hepatitis C: A survivor's guide, G. Everson, H. Weinberg, G. Everson, H. Weinberg. Hatherleigh, Long Island City, NY 2002; 72–91
   Google Scholar
• Fontana R., Schwartz S., Gebremariam S., Lok A., Moyer C. Emotional distress during Interferon-alpha2b and ribavirin treatment for chronic hepatitis C. Psychosomatics 2002; 43(5)378–385
   PubMedGoogle Scholar
• Forton D., Allsop J., Main J., Foster G., Thomas H., Taylor-Robinson S. Evidence for cerebral effect of the hepatitis C virus. Lancet 2001; 358: 38–39
   PubMed Web of Science ®Google Scholar
• Forton D., Thomas H., Murphy C., Allsop J., Foster G., Main J., Wesnes K., Taylor-Robinson S. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002; 33: 433–439
   Google Scholar
• Gifford S., O'Brien M., Bammer G., Banwell C., Stoove M. Australian women's experiences of living with hepatitis C virus: Results from a cross-sectional survey. Journal of Gastroenterology and Hepatology 2003; 18: 841–850
   PubMed Web of Science ®Google Scholar
• Gilden D. Treatment insider: Modest advances in Hep C treatment come at a hefty price. 2007, [On-line]. Retrieved April 5, 2007, from Amfar Global Link www.amfar.org
   Google Scholar
• Gill M., Atiq M., Sattar S., Khokhar N. Psychological implications of hepatitis C virus diagnosis. Journal of Gastroenterology and Hepatology 2005; 20: 1741–1744
   PubMedGoogle Scholar
• Gompf S. Side effects in interferon and ribavirin therapy of chronic viral hepatitis. eMedicine Newsletter 2005; 2(2)
   Google Scholar
• Heathcote J., Main J. Treatment of Hepatitis C. Journal of Viral Hepatology 2005; 12(3)223–235
   PubMedGoogle Scholar
• Heitkemper M., Jarrett M., Kurashige E., Carithers R. Chronic hepatitis C: Implications for health-related quality of life. Gastroenterology Nursing 2001; 24(4)169–175
   PubMedGoogle Scholar
• Hilsabeck R., Hassanein T., Carlson M., Ziegler E., Perry W. Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. Journal of the International Neuropsychological Society 2003; 9: 847–854
   PubMed Web of Science ®Google Scholar
• Hilsabeck R., Malek-Ahmadi P. Neurobehavioral correlates of chronic hepatitis C. Journal of Psychopathology and Behavioral Assessment 2004; 26(3)203–210
   Google Scholar
• Kalyoncu O., Tan D., Mirsal H., Pektas O., Beyazyurek M. Major depressive disorder with psychotic features induced by Interferon-alpha treatment for hepatitis C in a polydrug abuser. Journal of Psychopharmacology 2005; 19(1)102–105
   PubMedGoogle Scholar
• Kraus M., Schafer A., Faller H., et al. Psychiatric symptoms in patients with chronic hepatitis C receiving Interferon-alpha2b therapy. Journal of Clinical Psychiatry 2003; 64(6)708–714
   PubMed Web of Science ®Google Scholar
• Kraus M., Schafer A., Wissmann S., Reimer P., Scheurlen M. Neurocognitive changes in patients with hepatitis C receiving Interferon alpha2b and ribavirin. Clinical Pharmacology and Therapeutics 2005; 77(1)90–100
   PubMed Web of Science ®Google Scholar
• Leone N. The role of nursing in managing treatment-associated adverse effects in patients with hepatitis C. Gastroenterology Nursing 2002; 25(5)201–203
   PubMedGoogle Scholar
• Maddock C., Landau S., Barry K., Maulayah P., Hotopf M., Cleare J., Norris S., Pariante C. Psychopathological symptoms during Interferon-alpha and ribavirin treatment: Effects on virologic response. Molecular Psychiatry 2005; 10: 332–333
   PubMedGoogle Scholar
• National Institutes of Health. Chronic hepatitis C: Current disease management. 2007, [On-line]. Retrieved March 29, 2007, from www.digestive.niddk.nih.gov/ddiseases/pubs/chronichepc
   Google Scholar
• Onyike C., Bonner J., Lyketsos C., Treisman G. Mania during treatment of chronic hepatitis C with pegylated Interferon and ribavirin. The American Journal of Psychiatry 2004; 161(3)429–435
   PubMedGoogle Scholar
• Patten S., Barbui C. Drug-induced depression: A systematic review to inform clinical practice. Psychotherapy and Psychosomatics 2004; 73: 207–215
   PubMed Web of Science ®Google Scholar
• Poynard T., Cacoub P., Ratziu V., Myers R., Dezailles M., Mercadier A., Ghillani P., Charlotte F., Piette J., Moussalli J. Fatigue in patients with chronic hepatitis C. Journal of Viral Hepatitis 2002; 9(4)295–303
   PubMed Web of Science ®Google Scholar
• Raison C., Demetrashvili M., Capuron L., Miller A. Neuropsychiatric adverse effects of Interferon-alpha: Recognition and management. CNS Drugs 2005; 19(2)105–123
   PubMed Web of Science ®Google Scholar
• Ranjbar M., Houshang A., Alizadeh M. Management of antiviral induced anemia in HCV infected patients. Hepatitis Monthly 2005; 5(1)15–18
   Google Scholar
• Rifflet H., Vuillemin E., Oberti F., Duverger P., Laine P., Garre J., Cales P. Suicidal impulses in patients with chronic viral hepatitis C during or after therapy with Interferon alpha. Gastroenterologic Clinical Biology 1998; 22: 353–357
   PubMed Web of Science ®Google Scholar
• Robinson A. Meeting the psychological needs of Hepatitis C patients on combination therapy. Issues in Interdisciplinary Care 2001; 3(3)177–183
   Google Scholar
• Saunders J., Cookman C. A clarified conceptual meaning of hepatitis C-related depression. Gastroenterology Nursing 2005; 28(2)123–129
   PubMedGoogle Scholar
• Schaefer M., Schmidt F., Folwaczny C., Lorenz R., Martin G., Schindlbeck N., et al. Adherence and mental neuropsychiatric symptoms during hepatitis C treatment with Interferon alfa and ribavirin in psychiatric risk groups. Hepatology 2003; 37: 443–451
   PubMed Web of Science ®Google Scholar
• Simple Fact Sheet: Hepatitis C. 2006, [On-line]. Retrieved April 5, 2007, from www.atdn.org/simple/hepc
   Google Scholar
• Thierry P., Eve G., Xavier H., et al. Fatigue is associated with high circulating leptin levels in chronic hepatitis C. Gastroenterology 2002; 122: A M1589
   Google Scholar
• Wessely S., Pariante C. Fatigue, depression, and chronic hepatitis C infection. Psychological Medicine 2002; 32(1)1–10
   PubMed Web of Science ®Google Scholar
• Zickmund S., Ho E., Masuda M., Ippolito L., LaBrecque D. “They treated me like a leper”: Stigmatization and the quality of life of patients with hepatitis C. Journal of General Internal Medicine 2003; 18(10)835–844
   PubMed Web of Science ®Google Scholar